TABLE 1.

Referring institution versus MPCC diagnosis

Risk	Diagnosis	Referring institution (n = 262)	MPCC (n = 262)
No risk	No cyst	3 (1.1 %)	7 (2.7 %)
	Pseudocyst	3 (1.1 %)	3 (1.1 %)
Low	Serous cystadenoma	7 (2.7 %)	15 (5.7 %)
Intermediate	Branch duct IPMN	113 (43.1 %)	176 (67.2 %)
High	Main duct IPMN	3 (1.1 %)	2 (0.8 %)
	Mixed IPMN	2 (0.8 %)	3 (1.1 %)
	Mucinous cystic neoplasm	4 (1.5 %)	3 (1.1 %)
Malignant	Adenocarcinoma/adenocarcinoma arising in IPMN	5 (1.9 %)	8 (3.1 %)
	Pancreatic neuroendocrine tumor	0 (0 %)	6 (2.3 %)
	Solid pseudopapillary neoplasm	0 (0 %)	1 (0.4 %)
Unknown	Unclear type	122 (46.6 %)	38 (14.5 %)

MPCC multidisciplinary pancreatic cyst clinic, IPMN intraductal papillary mucinous neoplasm